Adaptogens MOC

Hub Notes

Ashwagandha — most validated Ayurvedic adaptogen; cortisol ↓19–32% via dual HPA-axis mechanisms; testosterone ↑17%; VO2max ↑; sleep ↑72%
Bacopa monnieri — most neuroimaging-validated Ayurvedic nootropic; CREB-BDNF → dendritic arborization confirmed by 3T MRI; AChE inhibition
Rhodiola rosea — stimulating adaptogen; CRF1 antagonism + monoamine modulation; best fit for stress fatigue, acute cognitive pressure, and mild depression rather than calm/sedation

BDNF NGF induction — Ashwagandha, Bacopa, and Rhodiola all intersect with neuroplasticity pathways, though by different upstream routes
GABA-A receptor — Ashwagandha and Bacopa have the clearest GABAergic overlap
HPA-axis modulation — all three matter here; Rhodiola is the stimulating CRF1/monoamine adaptogen, Ashwagandha the calming cortisol-focused anchor, Bacopa the slower neurocognitive support layer

Ashwagandha + Bacopa monnieri — complementary cortisol mechanisms; both Ayurvedic Rasayanas; neuroprotective dual-axis
Ashwagandha + Rhodiola rosea — stimulating + sedating adaptogen pair (Rhodiola = activating, Ashwagandha = calming)
Lion’s Mane + Bacopa monnieri — complementary BDNF pathways (TrkA/TrkB vs PI3K/AKT-CREB); different regulatory status

All three can affect cortisol / stress handling → HRV, sleep efficiency, and morning readiness interpretation
Ashwagandha: testosterone and VO2max relevance → body composition and aerobic capacity
Bacopa: episodic/working memory + anxiety reduction → cognitive coaching domains
Rhodiola: acute stress/fatigue support + insomnia risk if dosed late → strong wearable/confound relevance

Ashwagandha: cycling mandatory (8–12 wks on / 4 wks off)
Bacopa: 8–12 week minimum before efficacy assessment
Rhodiola: early-day dosing and strict dose discipline matter because the inverted-U curve is real
CYP / interaction risk varies by herb; none of these replace pharmaceutical interventions for diagnosed conditions